GLYCOMIRA

GlycoMira Therapeutics is a preclinical-stage biopharmaceutical company developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. GlycoMira's dedicated team is working tirelessly toward a vision that will transform the way cancer and other inflammatory diseases are treated.

Also known as: GlycoMira Therapeutics, GlycoMira Therapeutics, Inc.

Primary location: Salt Lake City United States